Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Lung Cancer

Free Subscription Articles published in Clin Exp Metastasis Retrieve available abstracts of 22 articles: HTML format

Single Articles

May 2025
1. YANG X, Chu X, Ye R, Ni J, et al
   Oligo-residual disease in metastatic ALK-positive NSCLC treated with alectinib.
   Clin Exp Metastasis. 2025;42:31.
   PubMed     Abstract available
   
   
   April 2025
2. ROQUET N, Beddok A, Loo M, Calais G, et al
   Post-operative hypofractionated stereotactic radiotherapy for brain metastases from lung and breast cancer in patients without prior WBRT: a retrospective dose escalation study.
   Clin Exp Metastasis. 2025;42:27.
   PubMed     Abstract available
   
   
   
3. YANG L, Li J
   Interplay of GPC3, Hsa-miR-135b-3p, and FTLP3 in lung cancer metastasis.
   Clin Exp Metastasis. 2025;42:26.
   PubMed     Abstract available
   
   
   March 2025
4. YANG J, Feng J, Duan Z, Liu X, et al
   Brain metastases lung adenocarcinoma patients with BRG1 loss have a grim prognosis, featuring unique morphological and methylation characteristics.
   Clin Exp Metastasis. 2025;42:20.
   PubMed     Abstract available
   
   
   
5. LIU Z, Song H, Wang Z, Hu Y, et al
   A novel optimized orthotopic mouse model for brain metastasis with sustained cerebral blood circulation and capability of multiple delivery.
   Clin Exp Metastasis. 2025;42:19.
   PubMed     Abstract available
   
   
   December 2024
6. RIZZO A, Monteiro FSM, Mollica V, Brunetti O, et al
   Metastatic sites and clinical outcomes in renal cell carcinoma patients receiving immune-based combinations: the MOUSEION-08 study.
   Clin Exp Metastasis. 2024;42:9.
   PubMed     Abstract available
   
   
   
7. HU X, Wu H, Hu K, Kang Y, et al
   Establishing patient-derived tumor organoids of bone metastasis from lung adenocarcinoma reveals the transcriptomic changes underlying denosumab treatment.
   Clin Exp Metastasis. 2024;42:8.
   PubMed     Abstract available
   
   
   
8. JASMER KJ, Shanbhag VC, Forti KM, Woods LT, et al
   Pulmonary lysyl oxidase expression and its role in seeding Lewis lung carcinoma cells.
   Clin Exp Metastasis. 2024;42:7.
   PubMed     Abstract available
   
   
   
9. SONG Y, Kim YJ, Choi S, Yun JK, et al
   Stereotactic ablative radiotherapy for pulmonary metastasis from sarcoma: a retrospective comparison with metastasectomy.
   Clin Exp Metastasis. 2024;42:2.
   PubMed     Abstract available
   
   
   
10. CAIVANO D, Pezzulla D, Bonome P, Ricciardi C, et al
    Multi-institutional study using sbrt to treat mediastinal and hilar lymphadenopathy.
    Clin Exp Metastasis. 2024;42:4.
    PubMed     Abstract available
    
    
    
11. HUNG SK, Yu CC, Lin HY, Chiou WY, et al
    Targeting PADI2 as a potential therapeutic strategy against metastasis in oral cancer via suppressing EMT-mediated migration and invasion and CCL3/5-induced angiogenesis.
    Clin Exp Metastasis. 2024;41:925-935.
    PubMed     Abstract available
    
    
    October 2024
12. HU Y, Lei W, Xin E, Cheng T, et al
    Factors associated with the distribution of brain metastases in lung cancer: a retrospective study.
    Clin Exp Metastasis. 2024 Oct 1. doi: 10.1007/s10585-024-10315.
    PubMed     Abstract available
    
    
    May 2024
13. BAUGH AG, Gonzalez E, Narumi VH, Kreger J, et al
    A new Neu-a syngeneic model of spontaneously metastatic HER2-positive breast cancer.
    Clin Exp Metastasis. 2024 May 8. doi: 10.1007/s10585-024-10289.
    PubMed     Abstract available
    
    
    April 2024
14. BHAT V, Piaseczny M, Goodale D, Patel U, et al
    Lung-derived soluble factors support stemness/plasticity and metastatic behaviour of breast cancer cells via the FGF2-DACH1 axis.
    Clin Exp Metastasis. 2024 Apr 6. doi: 10.1007/s10585-024-10284.
    PubMed     Abstract available
    
    
    
15. HAIDER MT, Freytag V, Krause L, Spethmann T, et al
    Comparison of ex vivo bioluminescence imaging, Alu-qPCR and histology for the quantification of spontaneous lung and bone metastases in subcutaneous xenograft mouse models.
    Clin Exp Metastasis. 2024;41:103-115.
    PubMed     Abstract available
    
    
    March 2024
16. OKUNO T, Isobe T, Tsubata Y
    Current pharmacologic treatment of brain metastasis in non-small cell lung cancer.
    Clin Exp Metastasis. 2024 Mar 11. doi: 10.1007/s10585-024-10276.
    PubMed     Abstract available
    
    
    February 2024
17. WIEGMANS AP, Ivanova E, Naei VY, Monkman J, et al
    Poor patient outcome correlates with active engulfment of cytokeratin positive CTCs within cancer-associated monocyte population in lung cancer.
    Clin Exp Metastasis. 2024 Feb 28. doi: 10.1007/s10585-024-10270.
    PubMed     Abstract available
    
    
    
18. POURJAMAL N, Yazdi N, Halme A, Joncour VL, et al
    Comparison of trastuzumab emtansine, trastuzumab deruxtecan, and disitamab vedotin in a multiresistant HER2-positive breast cancer lung metastasis model.
    Clin Exp Metastasis. 2024 Feb 17. doi: 10.1007/s10585-024-10278.
    PubMed     Abstract available
    
    
    
19. POPOV P, Steindl A, Wolff L, Bergen ES, et al
    Clinical characteristics, treatment, and outcome of patients with large cell neuroendocrine carcinoma of the lung and brain metastases - data from a tertiary care center.
    Clin Exp Metastasis. 2024;41:25-32.
    PubMed     Abstract available
    
    
    January 2024
20. HORIMOTO Y, Hlaing MT, Saeki H, Denda-Nagai K, et al
    Glycosylation profiles of breast cancer cells may represent clonal variations of multiple organ metastases.
    Clin Exp Metastasis. 2024 Jan 9. doi: 10.1007/s10585-023-10253.
    PubMed     Abstract available
    
    
    December 2023
21. BENZEKRY S, Schlicke P, Mogenet A, Greillier L, et al
    Computational markers for personalized prediction of outcomes in non-small cell lung cancer patients with brain metastases.
    Clin Exp Metastasis. 2023 Dec 20. doi: 10.1007/s10585-023-10245.
    PubMed     Abstract available
    
    
    October 2023
22. OYOSHI H, Hirata H, Hirano Y, Zenda S, et al
    Prognostic impact of EGFR/ALK alterations in leptomeningeal metastasis from lung adenocarcinoma treated with whole-brain radiotherapy.
    Clin Exp Metastasis. 2023;40:407-413.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.